BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= 019656
         (337 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
 pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
          Length = 265

 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 44  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 100

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 101 EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 160

Query: 205 RPKEL 209
           + + L
Sbjct: 161 KVESL 165


>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
 pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 41  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 97

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 98  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 157

Query: 205 RPKEL 209
           + + L
Sbjct: 158 KVESL 162


>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
 pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 260

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 39  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 95

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 96  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 155

Query: 205 RPKEL 209
           + + L
Sbjct: 156 KVESL 160


>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
 pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
          Length = 261

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 37  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 93

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 94  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 153

Query: 205 RPKEL 209
           + + L
Sbjct: 154 KVESL 158


>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 261

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 40  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 96

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 97  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 156

Query: 205 RPKEL 209
           + + L
Sbjct: 157 KVESL 161


>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
          Length = 260

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 39  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 95

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 96  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 155

Query: 205 RPKEL 209
           + + L
Sbjct: 156 KVESL 160


>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
 pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
          Length = 258

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 37  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 93

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 94  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 153

Query: 205 RPKEL 209
           + + L
Sbjct: 154 KVESL 158


>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
          Length = 259

 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 38  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 94

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 95  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 154

Query: 205 RPKEL 209
           + + L
Sbjct: 155 KVESL 159


>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
 pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
          Length = 256

 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K 
Sbjct: 35  RAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKF 91

Query: 147 EECQVPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGEC 204
           EE   P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C
Sbjct: 92  EEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANC 151

Query: 205 RPKEL 209
           + + L
Sbjct: 152 KVESL 156


>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
 pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
          Length = 262

 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|1VIN|A Chain A, Bovine Cyclin A3
          Length = 268

 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
 pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
          Length = 264

 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
 pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
          Length = 269

 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
 pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
          Length = 268

 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
          Length = 262

 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 45  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 101

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+ +    C+ + 
Sbjct: 102 PPEVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVES 161

Query: 209 L 209
           L
Sbjct: 162 L 162


>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
          Length = 261

 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 44  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 100

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+      C+ + 
Sbjct: 101 PPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVES 160

Query: 209 L 209
           L
Sbjct: 161 L 161


>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
 pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
          Length = 258

 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 41  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 97

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+      C+ + 
Sbjct: 98  PPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVES 157

Query: 209 L 209
           L
Sbjct: 158 L 158


>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
 pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
          Length = 257

 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 5/121 (4%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+      +  Q  T +L+V+++DRFLS  S+  GKL   +L+  A + LA+K EE  
Sbjct: 41  VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKL---QLVGTAAMLLASKFEEIY 97

Query: 151 VPALSEF-QVDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL-HYFMIKLCGECRPKE 208
            P ++EF  + D  +  K + RME LVL  L + + + T   FL  YF+      C+ + 
Sbjct: 98  PPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVES 157

Query: 209 L 209
           L
Sbjct: 158 L 158


>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
 pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
          Length = 269

 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           I+W+   +  F     T Y++V  +DRF+   S+    L   +L+ V  + +A+K EE  
Sbjct: 42  IDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKKML---QLVGVTAMFIASKYEEMY 98

Query: 151 VPALSEFQ-VDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL 193
            P + +F  V D  +    I++ME+ +L  L++ +G   P  FL
Sbjct: 99  PPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 142


>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
          Length = 283

 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 3/108 (2%)

Query: 91  IEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQ 150
           ++W+     ++     T YL+ DF DR+++ +      L  ++L+ ++ L +AAK+EE  
Sbjct: 54  LDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTL--LQLIGISSLFIAAKLEEIY 111

Query: 151 VPALSEFQ-VDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFLHYFM 197
            P L +F  V D       I  MEL+++  L W++  +T  ++L+ +M
Sbjct: 112 PPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSWLNVYM 159


>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
          Length = 260

 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 4/108 (3%)

Query: 87  RLDAIEWIFNKRAMFGFQFRTAYLSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKM 146
           R   I+W+   +  F     T Y++V  +DRF+    +    L   +L+ V  + +A+K 
Sbjct: 36  RAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKML---QLVGVTAMFIASKY 92

Query: 147 EECQVPALSEFQ-VDDFDFENKVIQRMELLVLSTLDWKMGSITPFAFL 193
           EE   P + +F  V D  +    I++ME+ +L  L++ +G   P  FL
Sbjct: 93  EEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 140


>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 257

 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 63/113 (55%), Gaps = 6/113 (5%)

Query: 110 LSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQVPALSEFQ--VDDFDFENK 167
           L++++LDRFLS   +   +L   +LL   C+ +A+KM+E  +P  +E      D     +
Sbjct: 66  LAMNYLDRFLSLEPVKKSRL---QLLGATCMFVASKMKET-IPLTAEKLCIYTDNSIRPE 121

Query: 168 VIQRMELLVLSTLDWKMGSITPFAFLHYFMIKLCGECRPKELVSRAVELIMTI 220
            + +MELL+++ L W + ++TP  F+ +F+ K+      K+++ +  +  + +
Sbjct: 122 ELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVAL 174


>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 271

 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 69/126 (54%), Gaps = 7/126 (5%)

Query: 110 LSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQVPALSEFQ--VDDFDFENK 167
           L++++LDRFLS   +   +L   +LL   C+ +A+KM+E  +P  +E      D     +
Sbjct: 80  LAMNYLDRFLSLEPVKKSRL---QLLGATCMFVASKMKE-TIPLTAEKLCIYTDNSIRPE 135

Query: 168 VIQRMELLVLSTLDWKMGSITPFAFLHYFMIKLCGECRPKELVSRAVELIMTITKV-INL 226
            + +MELL+++ L W + ++TP  F+ +F+ K+      K+++ +  +  + +    +  
Sbjct: 136 ELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKF 195

Query: 227 MNHRPS 232
           +++ PS
Sbjct: 196 ISNPPS 201


>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
 pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
          Length = 306

 Score = 39.7 bits (91), Expect = 0.002,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 110 LSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQVPALSEFQV-DDFDFENKV 168
           L++++LDR+LS       +L   +LL   C+ LA+K+ E     + +  +  D     + 
Sbjct: 94  LAMNYLDRYLSCVPTRKAQL---QLLGAVCMLLASKLRETTPLTIEKLCIYTDHAVSPRQ 150

Query: 169 IQRMELLVLSTLDWKMGSITPFAFLHYFMIKL 200
           ++  E+LVL  L W + ++    FL + + +L
Sbjct: 151 LRDWEVLVLGKLKWDLAAVIAHDFLAFILHRL 182


>pdb|3PUF|A Chain A, Crystal Structure Of Human Rnase H2 Complex
 pdb|3PUF|D Chain D, Crystal Structure Of Human Rnase H2 Complex
 pdb|3PUF|G Chain G, Crystal Structure Of Human Rnase H2 Complex
 pdb|3PUF|J Chain J, Crystal Structure Of Human Rnase H2 Complex
 pdb|3PUF|M Chain M, Crystal Structure Of Human Rnase H2 Complex
 pdb|3PUF|P Chain P, Crystal Structure Of Human Rnase H2 Complex
          Length = 302

 Score = 36.2 bits (82), Expect = 0.025,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 34/57 (59%), Gaps = 9/57 (15%)

Query: 52  EFIEKLVDKETDFGSKGCGFSDDCSTRTQSWLKCARLDAIEWIFNKRAMFGFQFRTA 108
           +F+EKL D +TD+GS   G+ +D   +T++WLK    + +E +F       F +RTA
Sbjct: 197 QFVEKLQDLDTDYGS---GYPND--PKTKAWLK----EHVEPVFGFPQFVRFSWRTA 244


>pdb|3P56|A Chain A, The Structure Of The Human Rnase H2 Complex Defines Key
           Interaction Interfaces Relevant To Enzyme Function And
           Human Disease
 pdb|3P56|D Chain D, The Structure Of The Human Rnase H2 Complex Defines Key
           Interaction Interfaces Relevant To Enzyme Function And
           Human Disease
          Length = 299

 Score = 36.2 bits (82), Expect = 0.025,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 34/57 (59%), Gaps = 9/57 (15%)

Query: 52  EFIEKLVDKETDFGSKGCGFSDDCSTRTQSWLKCARLDAIEWIFNKRAMFGFQFRTA 108
           +F+EKL D +TD+GS   G+ +D   +T++WLK    + +E +F       F +RTA
Sbjct: 194 QFVEKLQDLDTDYGS---GYPND--PKTKAWLK----EHVEPVFGFPQFVRFSWRTA 241


>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
           Cyclin
 pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
           Complex With A Flavonol Inhibitor, Fisetin
 pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
           Inhibitor Pd0332991
 pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
           Aminopurvalanol
          Length = 254

 Score = 27.7 bits (60), Expect = 8.7,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 48/108 (44%), Gaps = 9/108 (8%)

Query: 110 LSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQVPALSEFQVDDFD-FENKV 168
           LSV  LDR+L K+    G    ++ +  AC+ + +K+   +   +S+      D F N  
Sbjct: 75  LSVSILDRYLCKKQ---GTKKTLQKIGAACVLIGSKIRTVKPMTVSKLTYLSCDCFTNLE 131

Query: 169 IQRMELLVLSTLDWKMGSITPFAFLHYFMIKLCGECR-PKELVSRAVE 215
           +   E  +L  L W   ++        F+I LC   + P++L  +  E
Sbjct: 132 LINQEKDILEALKWDTEAV----LATDFLIPLCNALKIPEDLWPQLYE 175


>pdb|4GCM|A Chain A, Crystal Structure Of A Thioredoxine Reductase (Trxb) From
           Staphylococcus Aureus Subsp. Aureus Mu50 At 1.80 A
           Resolution
 pdb|4GCM|B Chain B, Crystal Structure Of A Thioredoxine Reductase (Trxb) From
           Staphylococcus Aureus Subsp. Aureus Mu50 At 1.80 A
           Resolution
          Length = 312

 Score = 27.7 bits (60), Expect = 9.0,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 21/35 (60%), Gaps = 5/35 (14%)

Query: 33  CDGSYYCDPCCFVLGNGD---EE--FIEKLVDKET 62
           CDG+++ +   FV+G GD   EE  F+ K  DK T
Sbjct: 138 CDGAFFKNKRLFVIGGGDSAVEEGTFLTKFADKVT 172


>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
          Length = 229

 Score = 27.7 bits (60), Expect = 9.4,   Method: Compositional matrix adjust.
 Identities = 28/108 (25%), Positives = 48/108 (44%), Gaps = 9/108 (8%)

Query: 110 LSVDFLDRFLSKRSIDDGKLWAIRLLSVACLSLAAKMEECQVPALSEFQVDDFD-FENKV 168
           LSV  LDR+L K+    G    ++ +  AC+ + +K+   +   +S+      D F N  
Sbjct: 54  LSVSILDRYLCKK---QGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLTYLSCDCFTNLE 110

Query: 169 IQRMELLVLSTLDWKMGSITPFAFLHYFMIKLCGECR-PKELVSRAVE 215
           +   E  +L  L W   ++    FL    I LC   + P++L  +  E
Sbjct: 111 LINQEKDILEALKWDTEAVLATDFL----IPLCNALKIPEDLWPQLYE 154


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.323    0.138    0.430 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,897,196
Number of Sequences: 62578
Number of extensions: 321372
Number of successful extensions: 617
Number of sequences better than 100.0: 33
Number of HSP's better than 100.0 without gapping: 23
Number of HSP's successfully gapped in prelim test: 10
Number of HSP's that attempted gapping in prelim test: 568
Number of HSP's gapped (non-prelim): 33
length of query: 337
length of database: 14,973,337
effective HSP length: 99
effective length of query: 238
effective length of database: 8,778,115
effective search space: 2089191370
effective search space used: 2089191370
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 52 (24.6 bits)